Cargando…
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
BACKGROUND: Immune checkpoint inhibitors (ICI) have emerged as active therapies in the management of advanced RCC. While multiple studies have shown clinical activity of ICIs in clear cell histologies, the evidence to support their use in non-clear cell (ncc) subtypes is based on smaller prospective...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490428/ https://www.ncbi.nlm.nih.gov/pubmed/36212797 http://dx.doi.org/10.3233/KCA-210012 |